相关实验视频

Updated: Feb 22, 2026

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications

Published on: November 17, 2015

基于胆固醇的脂质纳米颗粒作为细胞内药物储存库,用于增强瘤治疗

Qi Jiang¹, Yihe Qiu¹, Peirong Li¹

¹College of Pharmaceutical Science, Zhejiang University, Hangzhou, Zhejiang, 310058, People's Republic of China.

Pharmaceutical research

|February 20, 2026

概括

基于胆固醇的脂质纳米粒子 (Cls-LNPs) 作为细胞内药物储存器,改善癌症治疗. 这些新型纳米粒子增强药物保留和疗效,为癌症治疗提供了一个有前途的策略.

科学领域:

生物医学工程生物医学工程
纳米技术纳米技术
在瘤学瘤学.

背景情况:

癌症是一个重大的公共卫生挑战.
由于药物半衰期短,常规化疗也面临局限性,需要频繁给予.
增强细胞内药物积累对于改善治疗结果至关重要.

研究的目的:

开发生物相容的基于胆固醇的脂质纳米颗粒 (Cls-LNPs) 作为"细胞内药物储存库".
为了增强细胞吸收和保留抗瘤药物.
改善细胞内药物积累,以更好地治疗癌症.

主要方法:

合成了基于胆固醇的脂质纳米粒子 (Cls-LNPs).
Cls-LNPs的设计旨在逃避溶酶体降解,并准内质网膜 (ER).
载有Ce6的Cls-LNPs (Ce6@Cls-LNPs) 的疗效与光动力学疗法 (PDT) 结合在体外和体内进行了评估.

主要成果:

通过逃避 lysosomal 降解和准 ER,Cls-LNPs 证明了有效的细胞内药物储存能力.
与PDT结合的Ce6@Cls-LNPs与免费药物相比显示出更高的抗瘤疗效.
治疗诱导了ER压力,脂质过氧化和亡,具有显著的旁观者效应.

结论:

基于胆固醇的脂质纳米颗粒显示出作为创新的药物输送系统的潜力.
可以利用Cls-LNP来创建用于癌症治疗的增强保留的配方.
这项研究突出了改善抗瘤药物递送和疗效的新策略.

关键词:

胆固醇胆固醇胆固醇是一种细胞内药物储存库细胞内药物储存库脂质纳米颗粒的使用方法瘤治疗的治疗方法

更多相关视频

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Published on: August 2, 2016

相关概念视频

Bioavailability Enhancement: Drug Permeability Enhancement

Bioavailability Enhancement: Drug Permeability Enhancement

Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

Modified-Release Drug Delivery Systems: Site-Targeted

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

Drug Distribution: Tissue Binding

Drug Distribution: Tissue Binding

Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...